NBIX logo

Neurocrine Biosciences (NBIX) Non current assets

Annual non current assets:

$1.99B+$349.60M(+21.26%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NBIX annual long term assets is $1.99 billion, with the most recent change of +$349.60 million (+21.26%) on December 31, 2024.
  • During the last 3 years, NBIX annual non current assets has risen by +$894.30 million (+81.32%).
  • NBIX annual non current assets is now at all-time high.

Performance

NBIX Non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

quarterly non current assets:

$2.05B+$55.80M(+2.80%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NBIX quarterly long term assets is $2.05 billion, with the most recent change of +$55.80 million (+2.80%) on March 31, 2025.
  • Over the past year, NBIX quarterly non current assets has increased by +$376.40 million (+22.49%).
  • NBIX quarterly non current assets is now at all-time high.

Performance

NBIX quarterly non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Non current assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

NBIX Non current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+21.3%+22.5%
3 y3 years+81.3%+82.0%
5 y5 years+319.8%+420.6%

NBIX Non current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+117.9%at high+124.0%
5 y5-yearat high+319.8%at high+492.9%
alltimeall timeat high>+9999.0%at high>+9999.0%

NBIX Non current assets History

DateAnnualQuarterly
Mar 2025
-
$2.05B(+2.8%)
Dec 2024
$1.72B(+7.3%)
$1.99B(+20.2%)
Sep 2024
-
$1.66B(+1.4%)
Jun 2024
-
$1.64B(-2.3%)
Mar 2024
-
$1.67B(+1.8%)
Dec 2023
$1.61B(+10.6%)
$1.64B(+37.2%)
Sep 2023
-
$1.20B(+7.3%)
Jun 2023
-
$1.12B(+20.4%)
Mar 2023
-
$927.00M(+1.3%)
Dec 2022
$1.45B(+49.4%)
$915.20M(-2.4%)
Sep 2022
-
$937.90M(-4.9%)
Jun 2022
-
$986.40M(-12.4%)
Mar 2022
-
$1.13B(+2.4%)
Dec 2021
$972.80M(-4.3%)
$1.10B(+8.7%)
Sep 2021
-
$1.01B(+19.5%)
Jun 2021
-
$846.30M(+11.2%)
Mar 2021
-
$761.00M(+5.9%)
Dec 2020
$1.02B(+22.3%)
$718.50M(+107.8%)
Sep 2020
-
$345.70M(-6.4%)
Jun 2020
-
$369.40M(-6.2%)
Mar 2020
-
$393.70M(-17.1%)
Dec 2019
$831.00M(+12.6%)
$475.00M(+31.7%)
Sep 2019
-
$360.70M(+13.4%)
Jun 2019
-
$318.05M(-2.0%)
Mar 2019
-
$324.53M(+27.1%)
Dec 2018
$737.78M(+33.0%)
$255.37M(+16.4%)
Sep 2018
-
$219.35M(-19.8%)
Jun 2018
-
$273.64M(-6.5%)
Mar 2018
-
$292.64M(+11.4%)
Dec 2017
$554.92M(+78.8%)
$262.67M(+17.3%)
Sep 2017
-
$224.01M(+3.1%)
Jun 2017
-
$217.34M(+335.4%)
Mar 2017
-
$49.91M(-8.7%)
Dec 2016
$310.44M(-19.2%)
$54.64M(+32.4%)
Sep 2016
-
$41.27M(+9.0%)
Jun 2016
-
$37.87M(-35.1%)
Mar 2016
-
$58.35M(-35.7%)
Dec 2015
$384.07M(+93.8%)
$90.71M(-17.3%)
Sep 2015
-
$109.65M(-10.0%)
Jun 2015
-
$121.79M(-0.8%)
Mar 2015
-
$122.83M(+174.0%)
Dec 2014
$198.20M(+33.5%)
$44.83M(-39.3%)
Sep 2014
-
$73.88M(+2.7%)
Jun 2014
-
$71.96M(+25.0%)
Mar 2014
-
$57.56M(+826.3%)
Dec 2013
$148.46M(-21.6%)
$6.21M(-7.9%)
Sep 2013
-
$6.75M(-64.4%)
Jun 2013
-
$18.96M(-19.4%)
Mar 2013
-
$23.53M(+250.4%)
Dec 2012
$189.26M(+42.9%)
$6.71M(-55.9%)
Sep 2012
-
$15.23M(-26.9%)
Jun 2012
-
$20.83M(-17.2%)
Mar 2012
-
$25.17M(+327.1%)
Dec 2011
$132.48M(-0.4%)
$5.89M(-54.3%)
Sep 2011
-
$12.90M(+75.1%)
Jun 2011
-
$7.37M(-0.6%)
Mar 2011
-
$7.41M(-34.8%)
Dec 2010
$133.05M
$11.37M(-38.0%)
DateAnnualQuarterly
Sep 2010
-
$18.34M(+62.6%)
Jun 2010
-
$11.28M(-2.3%)
Mar 2010
-
$11.55M(-25.1%)
Dec 2009
$55.39M(-32.0%)
$15.43M(-12.9%)
Sep 2009
-
$17.72M(-46.4%)
Jun 2009
-
$33.09M(-2.2%)
Mar 2009
-
$33.82M(-8.0%)
Dec 2008
$81.42M(-55.5%)
$36.76M(-66.3%)
Sep 2008
-
$108.92M(-2.8%)
Jun 2008
-
$112.04M(+22.2%)
Mar 2008
-
$91.68M(-2.2%)
Dec 2007
$182.95M(-5.5%)
$93.71M(-50.5%)
Sep 2007
-
$189.32M(-1.0%)
Jun 2007
-
$191.27M(-1.1%)
Mar 2007
-
$193.40M(-1.3%)
Dec 2006
$193.66M(-30.7%)
$196.02M(-1.7%)
Sep 2006
-
$199.35M(-1.3%)
Jun 2006
-
$201.92M(-0.4%)
Mar 2006
-
$202.68M(-0.6%)
Dec 2005
$279.31M(-11.0%)
$203.81M(+0.2%)
Sep 2005
-
$203.34M(-0.3%)
Jun 2005
-
$203.99M(-0.7%)
Mar 2005
-
$205.33M(-0.0%)
Dec 2004
$313.81M(-33.5%)
$205.40M(-4.9%)
Sep 2004
-
$215.96M(+2.6%)
Jun 2004
-
$210.43M(+7.6%)
Mar 2004
-
$195.62M(+135.3%)
Dec 2003
$471.81M(+90.2%)
$83.15M(-5.5%)
Sep 2003
-
$88.03M(+50.6%)
Jun 2003
-
$58.46M(+175.3%)
Mar 2003
-
$21.23M(+15.1%)
Dec 2002
$248.09M(-25.2%)
$18.45M(+5.2%)
Sep 2002
-
$17.53M(+4.5%)
Jun 2002
-
$16.77M(+14.2%)
Mar 2002
-
$14.68M(-1.1%)
Dec 2001
$331.51M(+92.3%)
$14.84M(-2.9%)
Sep 2001
-
$15.29M(+3.4%)
Jun 2001
-
$14.79M(+6.0%)
Mar 2001
-
$13.95M(+2.9%)
Dec 2000
$172.41M(+81.9%)
$13.56M(-0.6%)
Sep 2000
-
$13.64M(-7.9%)
Jun 2000
-
$14.81M(+3.0%)
Mar 2000
-
$14.38M(-0.1%)
Dec 1999
$94.80M(+44.5%)
$14.40M(+2.1%)
Sep 1999
-
$14.10M(0.0%)
Jun 1999
-
$14.10M(-0.7%)
Mar 1999
-
$14.20M(-4.7%)
Dec 1998
$65.60M(-14.1%)
$14.90M(-21.6%)
Sep 1998
-
$19.00M(+11.8%)
Jun 1998
-
$17.00M(+11.8%)
Mar 1998
-
$15.20M(-1.9%)
Dec 1997
$76.40M(+6.0%)
$15.50M(+36.0%)
Sep 1997
-
$11.40M(0.0%)
Jun 1997
-
$11.40M(+72.7%)
Mar 1997
-
$6.60M(+11.9%)
Dec 1996
$72.10M
$5.90M(0.0%)
Sep 1996
-
$5.90M(+18.0%)
Jun 1996
-
$5.00M(+19.0%)
Mar 1996
-
$4.20M

FAQ

  • What is Neurocrine Biosciences annual long term assets?
  • What is the all time high annual non current assets for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual non current assets year-on-year change?
  • What is Neurocrine Biosciences quarterly long term assets?
  • What is the all time high quarterly non current assets for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly non current assets year-on-year change?

What is Neurocrine Biosciences annual long term assets?

The current annual non current assets of NBIX is $1.99B

What is the all time high annual non current assets for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual long term assets is $1.99B

What is Neurocrine Biosciences annual non current assets year-on-year change?

Over the past year, NBIX annual long term assets has changed by +$349.60M (+21.26%)

What is Neurocrine Biosciences quarterly long term assets?

The current quarterly non current assets of NBIX is $2.05B

What is the all time high quarterly non current assets for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly long term assets is $2.05B

What is Neurocrine Biosciences quarterly non current assets year-on-year change?

Over the past year, NBIX quarterly long term assets has changed by +$376.40M (+22.49%)
On this page